Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Prashanth Kumar Kolluri"'
Publikováno v:
Journal of Heterocyclic Chemistry. 57:4078-4087
Autor:
N.J.P. Subhashini, Appaji Dokala, E. Praveenkumar, Nirmala Gurrapu, Prashanth Kumar Kolluri, Shivaraj
Publikováno v:
Bioorganic chemistry. 116
CDK4 & CDK6 are essential regulators of initial cell cycle phases and are always considered an exciting choice for anti-cancer therapy. In the present study, we presented the structure-based rational design & synthesis of a new class of 1,2,3-triazol
Autor:
Prashanth Kumar Kolluri, Nirmala Gurrapu, Surya S. Singh, N.J.P. Subhashini, Shravani Putta, Praveen Kumar Edigi
Publikováno v:
Journal of Heterocyclic Chemistry. 56:3244-3256
Autor:
Vishwanadham Yerragunta, Prashanth Kumar Kolluri, N.J.P. Subhashini, E. Praveenkumar, Nirmala Gurrapu, Bharathi Reddy Kunduru
Publikováno v:
Bioorganic chemistry. 90
11-Beta-Hydroxysteroid dehydrogenase-1(11β-HSD1) inhibitors are one of the emerging classes of molecules to fight against diabetic complications. A novel series of 4-(1-substituted-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine derivatives were synthesi
Autor:
Prashanth Kumar Kolluri, N.J.P. Subhashini, E. Praveen Kumar, Nirmala Gurrapu, Sree Kanth Sivan, Shravani Putta
Publikováno v:
Journal of Molecular Structure. 1217:128356
As a part of our ongoing effort in a way to develop potential anti-cancer agents, a novel series of nine 1,2,3-triazole tethered chalcone hybrids were synthesized in good yields from suitable reaction procedures and were further characterized by vari
Autor:
N.J.P. Subhashini, Shravani Putta, Prashanth Kumar Kolluri, Tamalapakula Vani, Vijjulatha Manga, Surya Sathyanarayana Singh, Nirmala Gurrapu
Publikováno v:
Journal of Molecular Structure. 1202:127300
In an attempt to discover potential cytotoxic agents, a series of novel (Z)-2-(3-(4-((3-benzyl-2,4-dioxothiazolidin-5-ylidene)methyl)-1-phenyl-1H-pyrazol-3-yl) phenoxy)-N-arylacetamide derivatives 11a-n were synthesized in varied steps with acceptabl